Nuvectis Pharma raises ~$15.9M in private placement of common stock and warrants

Nuvectis Pharma, Inc.

Gross proceeds $15.9M from sale of 1,924,689 shares or pre-funded warrants at $8.25 per share plus preferred investment options.
Preferred investment options exercisable at $9.65, lockout 6 months, term 3.5 years.
H.C. Wainwright acted as placement agent with 7% cash fee plus 115,481 placement agent warrants at $10.3125.
Net proceeds intended for working capital and general corporate purposes.
Closing expected July 29, 2022, subject to customary conditions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.